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AcetAminophen-induced liveR injuRy  
in expeRimentAl AnimAls And humAns
H. Jaeschke*
Pharmacology, Toxicology & Therapeutics, The University of 
Kansas Medical Center, Kansas City, Kansas
Summary: Acetaminophen (APAP) or paracetamol hepatotoxicity is 
the most frequent cause of acute liver failure in the United States and 
many European countries. Animal studies have shown that the small 
fraction of the dose that is metabolized by cytochrome P-450 enzymes 
leads to formation of a reactive metabolite (NAPQI), which can be 
conjugated with glutathione but also binds to proteins. Although 
protein adduct formation, especially in mitochondria, correlates with 
cell toxicity, it is insufficient to trigger cell death. Instead, the initial 
mitochondrial dysfunction causes oxidant stress, which induces activa-
tion of MAP kinases ultimately causing c-jun-N-terminal kinase (JNK) 
phosphorylation and translocation to the mitochondria where P-JNK 
amplifies the oxidant stress and peroxynitrite formation. The enhanced 
mitochondrial oxidant stress together with translocation of lysosomal 
iron causes the membrane permeability transition pore (MPT) opening, 
resulting in the collapse of the membrane potential and cessation of 
ATP synthesis. The MPT also leads to mitochondrial matrix swell-
ing, which causes the rupture of the outer membrane with release of 
endonuclease G and apoptosis-inducing factor and translocation to the 
nucleus, where these enzymes induce DNA fragmentation. The loss of 
mitochondrial function and the nuclear DNA fragmentation are key 
events in APAP-induced cell necrosis. The massive cell necrosis leads to 
the release of damage-associated molecular patterns, which, through 
activation of toll-like receptors on macrophages, trigger cytokine 
formation and leukocyte activation and recruitment. However, the 
preponderance of the experimental evidence suggests that this inflam-
matory response has limited effect on the injury but results in the 
preparation of the regenerative or repair phase.
Although there has been enormous progress in understanding 
mechanisms of APAP-induced liver injury in animals, the insight into 
the human pathophysiology is more limited. However, in both human 
hepatocytes and in overdose patients, there is emerging evidence for 
the formation of protein adducts, the central role of mitochondrial 
damage and nuclear DNA fragmentation in necrotic cell death, and 
the repair function of inflammatory cells.
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QuAntifying the impAct of neviRApine-
bAsed pRophylAxis stRAtegies to pRevent 
motheR-to-child tRAnsmission of hiv-1 
using the populAtion AppRoAch
C. Kloft*
Freie Universitaet Berlin, Berlin, Germany
Summary: In 2011, a total of 330,000 (280,000–390,000) children 
acquired HIV infections predominantly during pregnancy, delivery, 
or breastfeeding in Africa,1 emphasizing the urgent need of effec-
tive strategies to prevent mother-to-child transmission of HIV-1 
(PMTCT). Several medicines and dosing regimens have been sug-
gested as PMTCT. Studies about these prevention strategies suffer 
from several constraints: due to resource limitations and to ethical 
reasons, intensive sampling is not feasible, typically resulting in a 
very sparse data situation. Hence, concepts capable of dealing with 
these situations seem very attractive: Pharmacometrics as an emerg-
ing science based on a transdisciplinary approach bridging ideas of 
biology, pharmacology, clinical pharmacy and pharmacology, medi-
cine, mathematics, and statistics represents an attractive framework 
to understand drug–patient interactions for optimizing prevention or 
treatment strategies. In detail, pharmacokinetic/pharmacodynamic/
biomarker/disease modeling by the population approach aims to elu-
cidate the mechanism-based relationships between dose exposure/
response while incorporating knowledge of the patients and their 
disease.2
In the presentation, the population analysis approach, its ben-
efits, and limitations will be explained and illustrated by an inves-
tigation of a PMTCT program containing nevirapine (NVP).3 For 
NVP: (1) the developed integrated pharmacokinetic model after 
oral administration to pregnant women and their newborns as well 
as derived stratified dosing strategies for different newborns will 
be demonstrated; and (2) how these concentration–time profiles 
of NVP were integrated into a stochastic model of HIV dynam-
ics (including the viral cycle in host cells) and transmission. Based 
on the final model, HIV transmission rates were predicted for a 
2-year period after birth which excellently agreed with data from 
7 independent PMTCT trials. Moreover, new mechanistic insights 
into transplacental transmission as well as resistance were gained, 
both with respect to the underlying NVP concentration–time pro-
files in pregnant women/mothers and newborns. The framework 
developed contributes to improve and guide PMTCT strategies in 
NVP prophylaxis regimens and more importantly in antiretroviral 
combination regimens.
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